POST Online Media Lite Edition



 

After two-year investigation New Hampshire sues Purdue Pharma for opioid crisis

Staff Writer |
The attorney general's office of New Hampshire has filed a lawsuit against Purdue Pharma alleging the drug manufacturer deceptively marketed OxyContin and worsened an opioid crisis.

Article continues below






Deputy Attorney General Ann M. Rice announced the lawsuit after a two-year investigation that concluded Purdue committed numerous violations to the state's Consumer Protection Act, Medicaid Fraud Act and other state laws.

In a statement, the state attorney general's office said the lawsuit alleges Purdue has engaged in unfair or deceptive marketing practices by "significantly downplaying the serious risk of addiction posed by OxyContin and other products; overstating the efficacy of chronic opioid therapy by claiming that OxyContin lasts for 12 hours when, for many patients, that is not true."

The lawsuit also alleges the company broke the law by "claiming that its product is tamper resistant and thereby nearly impossible to abuse when the product's tamper resistant properties are easily defeated; and by failing to report instances of suspicious dispensing of its products."


What to read next

EU launches probe into Aspen Pharma cancer drug pricing
Hampshire Group to sell Rio Garment of Honduras
Third time's not a charm: Depomed rejects Horizon Pharma again